- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 69-83 of
220 results
2019 Exhibit: Prodrugs of Phosphates, Phosphonates, and Phosphinates
Document
IPR2018-00123, No. 2019 Exhibit - Prodrugs of Phosphates, Phosphonates, and Phosphinates (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2001 Exhibit: Nucleoside Analog Inhibitors of Hepatitis C Virus Replication
Document
IPR2018-00123, No. 2001 Exhibit - Nucleoside Analog Inhibitors of Hepatitis C Virus Replication (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2021 Exhibit: Synergy of Small Molecular Inhibitors of Hepatitis C Virus Replication...
Document
IPR2018-00123, No. 2021 Exhibit - Synergy of Small Molecular Inhibitors of Hepatitis C Virus Replication Directed at Multiple Viral Targets (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2020 Exhibit: Targets and Tools Recent Advances in the Development of Anti HCV ...
Document
IPR2018-00123, No. 2020 Exhibit - Targets and Tools Recent Advances in the Development of Anti HCV Nucleic Acids (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2007 Exhibit: America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fu...
Document
IPR2018-00123, No. 2007 Exhibit - America¿¿¿s Overspend How the Pharmaceutical Patent Problem is Fueling High Drug Prices (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2022 Exhibit: Hepatitis C Virus Replication and Potential Targets for Direct Acting A...
Document
IPR2018-00123, No. 2022 Exhibit - Hepatitis C Virus Replication and Potential Targets for Direct Acting Agents (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2004 Exhibit: HARVONI¿¿ label
Document
IPR2018-00123, No. 2004 Exhibit - HARVONI¿¿ label (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2017 Exhibit: Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools f...
Document
IPR2018-00123, No. 2017 Exhibit - Pro Nucleotides ¿¿¿ Recent Advances in the Design of Efficient Tools for the Delivery of Biologically Active Nucleoside Monophosphates (P.T.A.B. Mar. 19, 2018...
|
|
Cite Document
2002 Exhibit: Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph
Document
IPR2018-00123, No. 2002 Exhibit - Curing Chronic Hepatitis C ¿¿¿ The Arc of a Medical Triumph (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2006 Exhibit: Clofarabine From Design to Approval
Document
IPR2018-00123, No. 2006 Exhibit - Clofarabine From Design to Approval (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2009 Exhibit: Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infe...
Document
IPR2018-00123, No. 2009 Exhibit - Development of Sofosbuvir for the Treatment of Hepatitis C Virus Infection (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2011 Exhibit: FDA Approves Pill to Treat Hepatitis C
Document
IPR2018-00123, No. 2011 Exhibit - FDA Approves Pill to Treat Hepatitis C (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2003 Exhibit: FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir
Document
IPR2018-00123, No. 2003 Exhibit - FDA Approves ¿¿¿Game Changer¿¿¿ Hepatitis C Drug Sofosbuvir (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2012 Exhibit: FDA Approves Gilead¿¿¿s Hepatitis C Drug
Document
IPR2018-00123, No. 2012 Exhibit - FDA Approves Gilead¿¿¿s Hepatitis C Drug (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
2010 Exhibit: Hepatitis C Deserves the Attention
Document
IPR2018-00123, No. 2010 Exhibit - Hepatitis C Deserves the Attention (P.T.A.B. Mar. 19, 2018)
|
|
Cite Document
